Search hospitals > Colorado > Denver
Denver Health Medical Center
Claim this profileDenver, Colorado 80204
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Wounds and Injuries
Conducts research for Tuberculosis
232 reported clinical trials
7 medical researchers
Summary
Denver Health Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Wounds and Injuries, Tuberculosis and other specialties. Denver Health Medical Center is involved with conducting 232 clinical trials across 471 conditions. There are 7 research doctors associated with this hospital, such as Ivor Douglas, MD, Ivor Douglass, MD, Jill Davies, MD, and Michael Hanley, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Ivor Douglas, MDDenver Health1 year of reported clinical research
Studies Sepsis
Studies Septic Shock
3 reported clinical trials
6 drugs studied
Ivor Douglass, MDDenver Health1 year of reported clinical research
Studies Respiratory Distress Syndrome
Studies Neonatal Respiratory Distress Syndrome
2 reported clinical trials
2 drugs studied
Jill Davies, MDDenver Health2 years of reported clinical research
Studies Hepatitis
Studies Hepatitis A
1 reported clinical trial
1 drug studied
Michael Hanley, MDDenver Health4 years of reported clinical research
Studies Lung Disease
Studies Chronic Bronchitis
1 reported clinical trial
2 drugs studied
Clinical Trials running at Denver Health Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Breast Cancer
Cardiac Arrest
Chronic Bronchitis
Chronic Obstructive Pulmonary Disease
ALK Gene Rearrangement
Mantle Cell Lymphoma
Prediabetes
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Denver Health Medical Center?
Denver Health Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Wounds and Injuries, Tuberculosis and other specialties. Denver Health Medical Center is involved with conducting 232 clinical trials across 471 conditions. There are 7 research doctors associated with this hospital, such as Ivor Douglas, MD, Ivor Douglass, MD, Jill Davies, MD, and Michael Hanley, MD.